查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813855

胸主動脈瘤市場規模、佔有率和趨勢分析報告：按治療、產品、最終用途、地區和細分市場預測，2025-2033 年

Thoracic Aortic Aneurysm Market Size, Share & Trends Analysis Report By Treatment (Open Surgical Repair (OSR), Thoracic Endovascular Aneurysm Repair (TEVAR)), By Product, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

胸主動脈瘤市場摘要

2024 年全球胸主動脈瘤市值估計為 16.5 億美元，預計到 2033 年將達到 50.4 億美元，2025 年至 2033 年的複合年成長率為 13.36%。

這種成長是由高血壓和結締組織疾病盛行率的上升、人口老化以及微創血管內治療的日益普及所推動的。

血管支架設計的技術進步、影像診斷技術的改進以及疾病的早期檢測正在推動市場擴張。支持性報銷政策以及醫生和患者對胸主動脈瘤認知的不斷提高，進一步加速了全球治療的普及。

高血壓、吸菸和動脈硬化是胸主動脈瘤的主要危險因素，這些因素的日益普及是市場成長的主要驅動力。隨著全球人口老化，退化性血管疾病的發生率持續上升，直接增加了對診斷和治療解決方案的需求。 2025年3月發表在《生物醫學》雜誌上的一篇論文分析了動脈粥樣硬化（AS）與主動脈瘤（AA）之間的關係，其中包括胸主動脈瘤（TAA）。研究發現，合併症發生率為18%至90%，並受動脈瘤位置、年齡、遺傳背景和二尖瓣主動脈瓣等因素的影響。

血管內動脈瘤修復 (TEVAR) 的技術進步提供了一種微創的開放性手術替代方案，從而顯著促進了市場的發展。這些創新縮短了住院時間，降低了手術風險，並擴大了高風險患者的治療範圍。設備製造商正在不斷開發下一代血管支架，以提高精度、靈活性和耐用性，進一步加速全球血管外科醫生對其的採用。 2025 年 5 月，達卡 SHIP 國際醫院為一名 57 歲的胸主動脈瘤 (TAA) 患者實施了胸主動脈血管內修復 (TEVAR)。在其他地方被拒絕治療後，該患者經 NICVD 的一位教授轉診，並在血管內血管支架移植物供應商的支持下接受了微創手術。

CT血管攝影、MRI和超音波等先進影像技術日益廣泛地應用於早期準確檢測胸主動脈瘤，推動了市場的成長。全國篩檢計畫以及臨床醫生和患者意識的提高，有助於早期診斷和及時干預。同時，人工智慧工具和數位健康平台正在整合到診斷流程中，以支援更完善的風險分層和病患監測。

2025年6月發表在《自然通訊》上的一篇論文描述了一個人工智慧模型，該模型能夠利用常規乳房MRI掃描對胸主動脈瘤（TAA）進行機會性篩檢。與標準臨床檢測相比，模型將檢出率提高了3.5倍。此模型根據主動脈大小以及AHI和ASI等體重調整指標來標記高風險患者。

全球胸主動脈瘤市場細分

全球胸主動脈瘤市場按全球、地區和國家/地區提供了最新趨勢分析，並預測了 2021 年至 2033 年每個細分市場的收益成長。本研究報告按治療、產品、最終用途和地區對全球胸主動脈瘤市場進行細分：

  • 治療展望（2021-2033）。
  • 開放性手術修復（OSR）。
  • 胸主動脈瘤腔內修復術（TEVAR）。
  • 分支血管內動脈瘤修復（BEVAR）。
  • 混合技術。
  • 產品展望（2021-2033）。
  • 主動脈血管支架。
  • 主動脈外科移植。
  • 主動脈修復附件裝置。
  • 最終用途展望（2021-2033）。
  • 醫院。
  • 門診手術中心（ASC）。
  • 診所。
  • 區域展望（2021-2033）。
  • 北美。
    • 美國。
    • 加拿大。
    • 墨西哥。
  • 歐洲。
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區。
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲。
    • 巴西
    • 阿根廷。
  • 中東和非洲。
    • 南非。
    • 沙烏地阿拉伯.
    • 阿拉伯聯合大公國.
    • 科威特。

目錄

第1章調查方法與範圍

第2章執行摘要

3. 全球胸主動脈瘤市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 補貼市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 全球胸主動脈瘤市場分析工具
    • 產業分析-波特五力分析
    • PESTLE分析
  • 治療狀況
  • 案例研究分析

4. 2021-2033 年全球胸主動脈瘤市場細分分析及治療

  • 定義和範圍
  • 2024 年及 2033 年治療市佔率分析
  • 細分儀表板
  • 全球胸主動脈瘤市場（治療，2021-2033）
  • 開放性手術修復（OSR）
    • 2021-2033年開放性手術修復（OSR）市場估計與預測
  • 胸主動脈瘤腔內修復術（TEVAR）
    • 2021-2033 年胸主動脈血管內動脈瘤修復 (TEVAR) 市場估計與預測
  • 混合程式
    • 2021-2033年混合手術市場估計與預測
  • 分支血管內動脈瘤修復術（BEVAR）
    • 2021-2033年分支血管內動脈瘤修復（BEVAR）市場預測與預測

5. 2021-2033 年全球胸主動脈瘤市場細分分析（按產品）

  • 定義和範圍
  • 2024年及2033年產品市佔率分析
  • 細分儀表板
  • 2021-2033年全球胸主動脈瘤市場（依產品）
  • 主動脈血管支架
    • 主動脈血管支架市場估計與預測（2021-2033年）
  • 主動脈外科移植
    • 2021-2033年主動脈外科移植市場估計與預測
  • 主動脈修復輔助裝置
    • 主動脈修復輔助裝置市場估計與預測（2021-2033年）

6. 2021-2033 年全球胸主動脈瘤市場細分分析（依最終用途）

  • 定義和範圍
  • 2024年及2033年最終用途市佔率分析
  • 細分儀表板
  • 2021-2033年全球胸主動脈瘤市場（依最終用途）
  • 醫院
    • 2021-2033年醫院市場估計與預測
  • 門診手術中心（ASC）
    • 門診手術中心 (ASC) 市場估計與預測（2021-2033 年）
  • 診所
    • 2021-2033年診所市場估計與預測

7. 2021-2033 年胸主動脈瘤市場細分分析（按地區）

  • 2024 年及 2033 年區域市佔率分析
  • 區域市場儀表板
  • 區域市場概況
  • 2024 年及 2033 年胸主動脈瘤市場各地區佔有率：
  • 北美洲
    • 2021-2033年北美胸主動脈瘤市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2021-2033年歐洲胸主動脈瘤市場
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 公司簡介
    • Medtronic plc
    • WL Gore &Associates, Inc.
    • Cook Medical Inc.
    • Terumo Corporation
    • MicroPort Scientific Corporation
    • Boston Scientific Corporation
    • Artivion Inc.
    • Cardiatis SA
    • Endologix Inc.
    • Braile Biomedica
    • Lombard Medical
    • CryoLife, Inc.
Product Code: GVR-4-68040-704-9

Thoracic Aortic Aneurysm Market Summary

The global thoracic aortic aneurysm market size was estimated at USD 1.65 billion in 2024 and is projected to reach USD 5.04 billion by 2033, growing at a CAGR of 13.36% from 2025 to 2033. This growth is driven by the rising prevalence of hypertension and connective tissue disorders, an increasing aging population, and growing adoption of minimally invasive endovascular procedures.

Technological advancements in stent graft design, improved diagnostic imaging, and early disease detection contribute to market expansion. Supportive reimbursement policies and expanding awareness of thoracic aortic aneurysms among both physicians and patients are further accelerating treatment uptake globally.

The increasing prevalence of hypertension, smoking, and atherosclerosis, which are key risk factors for thoracic aortic aneurysm, is a major driver of market growth. As aging populations grow globally, the incidence of degenerative vascular conditions continues to rise, directly increasing the demand for diagnostic and therapeutic solutions. In March 2025, an article published in Biomedicines analyzed the relationship between atherosclerosis (AS) and aortic aneurysm (AA), including thoracic AA (TAA). It reported comorbidity rates ranging from 18% to 90%, influenced by aneurysm location, age, genetic background, and bicuspid aortic valves.

Technological advancements in endovascular aneurysm repair (TEVAR) have significantly boosted the market by offering minimally invasive alternatives to open surgery. These innovations have led to reduced hospital stays, lower procedural risks, and expanded treatment eligibility for high-risk patients. Device manufacturers are continually developing next-generation stent grafts with enhanced precision, flexibility, and durability, further accelerating their adoption among vascular surgeons worldwide. In May 2025, SHIP International Hospital in Dhaka performed a Thoracic Endovascular Aortic Repair (TEVAR) on a 57-year-old patient with a thoracic aortic aneurysm (TAA), a bulge in the chest portion of the aorta. Referred by a NICVD professor after being denied treatment elsewhere, the patient underwent the minimally invasive procedure with support from an endovascular stent graft vendor.

The growing use of advanced imaging modalities such as CT angiography, MRI, and ultrasound for early and accurate detection of thoracic aortic aneurysms is fueling market growth. National screening programs and increased awareness among both clinicians and patients are contributing to earlier diagnosis and timely intervention. In parallel, artificial intelligence tools and digital health platforms are being integrated into diagnostic pathways, supporting better risk stratification and patient monitoring.

In June 2025, an article published in Nature Communications discussed an AI model that enables opportunistic screening for thoracic aortic aneurysms (TAA) using routine breast MRI scans. The model improved detection rates by 3.5X compared to standard clinical reads. It flagged high-risk patients based on both aortic size and body-size-adjusted indices like AHI and ASI.

Global Thoracic Aortic Aneurysm Market Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global thoracic aortic aneurysm market report based on treatment, product, end use, and region:

  • Treatment Outlook (Revenue USD Million, 2021 - 2033)
  • Open Surgical Repair (OSR)
  • Thoracic Endovascular Aneurysm Repair (TEVAR)
  • Branched Endovascular Aneurysm Repair (BEVAR)
  • Hybrid Procedures
  • Product Outlook (Revenue USD Million, 2021 - 2033)
  • Aortic Stent Grafts
  • Aortic Surgical Grafts
  • Aortic Repair Accessory Devices
  • End Use Outlook (Revenue USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgery Centers (ASC)
  • Clinics
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Treatment outlook
    • 2.2.2. Product outlook
    • 2.2.3. End use outlook
  • 2.3. Competitive Insights

Chapter 3. Global Thoracic Aortic Aneurysm Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Global Thoracic Aortic Aneurysm: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Treatment Landscape
  • 3.5. Case Study Analysis

Chapter 4. Global Thoracic Aortic Aneurysm Market Segment Analysis, By Treatment, 2021-2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Treatment Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Thoracic Aortic Aneurysm Market, by Treatment, 2021 to 2033
  • 4.5. Open Surgical Repair (OSR)
    • 4.5.1. Open surgical repair (OSR) market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Thoracic Endovascular Aneurysm Repair (TEVAR)
    • 4.6.1. Thoracic endovascular aneurysm repair (TEVAR) market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7. Hybrid Procedures
    • 4.7.1. Hybrid procedures market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.8. Branched Endovascular Aneurysm Repair (BEVAR)
    • 4.8.1. Branched endovascular aneurysm repair (BEVAR) market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Global Thoracic Aortic Aneurysm Market Segment Analysis, By Product, 2021-2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Product Market Share Analysis, 2024 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Global Thoracic Aortic Aneurysm Market, by Product, 2021 to 2033
  • 5.5. Aortic Stent Grafts
    • 5.5.1. Aortic stent grafts market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.6. Aortic Surgical Grafts
    • 5.6.1. Aortic surgical grafts market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.7. Aortic Repair Accessory Devices
    • 5.7.1. Aortic repair accessory devices market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Global Thoracic Aortic Aneurysm Market Segment Analysis, By End Use, 2021-2033 (USD Million)

  • 6.1. Definition and Scope
  • 6.2. End Use Market Share Analysis, 2024 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Global Thoracic Aortic Aneurysm Market, by End Use, 2021 to 2033
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6. Ambulatory surgery centers (ASC)
    • 6.6.1. Ambulatory surgery centers (ASC) market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.7. Clinics
    • 6.7.1. Clinics market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Thoracic Aortic Aneurysm Market Segment Analysis, By Region, 2021- 2033 (USD Million)

  • 7.1. Regional Market Share Analysis, 2024 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Thoracic Aortic Aneurysm Market Share by Region, 2024 & 2033:
  • 7.5. North America
    • 7.5.1. North America thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Scenario
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. U.S. thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Scenario
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Canada thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Scenario
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Mexico thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Scenario
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. UK thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Scenario
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Germany thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Scenario
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. France thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Scenario
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Italy thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Scenario
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Spain thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.6.7. Norway
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Regulatory Scenario
      • 7.6.7.3. Competitive Scenario
      • 7.6.7.4. Norway thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key Country Dynamics
      • 7.6.8.2. Regulatory Scenario
      • 7.6.8.3. Competitive Scenario
      • 7.6.8.4. Sweden thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.6.9. Denmark
      • 7.6.9.1. Key Country Dynamics
      • 7.6.9.2. Regulatory Scenario
      • 7.6.9.3. Competitive Scenario
      • 7.6.9.4. Denmark thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Scenario
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Japan thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Scenario
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. China thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Regulatory Scenario
      • 7.7.3.3. Competitive Scenario
      • 7.7.3.4. India thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Regulatory Scenario
      • 7.7.4.3. Competitive Scenario
      • 7.7.4.4. Australia thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Regulatory Scenario
      • 7.7.5.3. Competitive Scenario
      • 7.7.5.4. South Korea thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Regulatory Scenario
      • 7.7.6.3. Competitive Scenario
      • 7.7.6.4. Thailand thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Scenario
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. Brazil thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Scenario
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. Argentina thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key Country Dynamics
      • 7.9.1.2. Regulatory Scenario
      • 7.9.1.3. Competitive Scenario
      • 7.9.1.4. South Africa thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Regulatory Scenario
      • 7.9.2.3. Competitive Scenario
      • 7.9.2.4. Saudi Arabia thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Regulatory Scenario
      • 7.9.3.3. Competitive Scenario
      • 7.9.3.4. UAE thoracic aortic aneurysm market, 2021 - 2033 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Regulatory Scenario
      • 7.9.4.3. Competitive Scenario
      • 7.9.4.4. Kuwait thoracic aortic aneurysm market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Profiles
    • 8.3.1. Medtronic plc
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. W.L. Gore & Associates, Inc.
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Cook Medical Inc.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Terumo Corporation
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. MicroPort Scientific Corporation
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Boston Scientific Corporation
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Artivion Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Cardiatis S.A.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Endologix Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Braile Biomedica
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Lombard Medical
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. CryoLife, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 4 Global Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 5 Global Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 6 Global Thoracic Aortic Aneurysm Market, by Region, 2021 - 2033 (USD Million)
  • Table 7 North America Thoracic Aortic Aneurysm Market, by Country, 2021 - 2033 (USD Million)
  • Table 8 North America Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 9 North America Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 10 North America Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 11 U.S. Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 12 U.S. Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 13 U.S. Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 14 Canada Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 15 Canada Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 16 Canada Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 17 Mexico Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 18 Mexico Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 19 Mexico Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 20 Europe Thoracic Aortic Aneurysm Market, by Country, 2021 - 2033 (USD Million)
  • Table 21 Europe Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 22 Europe Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 23 Europe Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 24 UK Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 25 UK Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 26 UK Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 27 Germany Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 28 Germany Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 29 Germany Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 30 France Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 31 France Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 32 France Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 33 Italy Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 34 Italy Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 35 Italy Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 36 Spain Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 37 Spain Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 38 Spain Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 39 Denmark Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 40 Denmark Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 41 Denmark Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 42 Sweden Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 43 Sweden Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 44 Sweden Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 45 Norway Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 46 Norway Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 47 Norway Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Thoracic Aortic Aneurysm Market, by Country, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 52 Japan Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 53 Japan Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 54 Japan Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 55 China Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 56 China Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 57 China Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 58 India Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 59 India Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 60 India Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 61 Australia Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 62 Australia Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 63 Australia Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 64 Thailand Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 65 Thailand Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 66 Thailand Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 67 South Korea Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 68 South Korea Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 69 South Korea Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 70 Latin America Thoracic Aortic Aneurysm Market, by Country, 2021 - 2033 (USD Million)
  • Table 71 Latin America Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 72 Latin America Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 73 Latin America Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 74 Brazil Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 75 Brazil Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 76 Brazil Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 77 Argentina Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 78 Argentina Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 79 Argentina Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa Thoracic Aortic Aneurysm Market, by Country, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 83 Middle East & Africa Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 84 South Africa Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 85 South Africa Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 86 South Africa Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 89 Saudi Arabia Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 90 UAE Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 91 UAE Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 92 UAE Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Thoracic Aortic Aneurysm Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Thoracic Aortic Aneurysm Market, by Product, 2021 - 2033 (USD Million)
  • Table 95 Kuwait Thoracic Aortic Aneurysm Market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Global thoracic aortic aneurysm market: outlook
  • Fig. 9 Global thoracic aortic aneurysm competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Ancillary market outlook
  • Fig. 12 Global thoracic aortic aneurysm market driver impact
  • Fig. 13 Global thoracic aortic aneurysm market restraint impact
  • Fig. 14 Porter's Analysis
  • Fig. 15 PESTLE Analysis
  • Fig. 16 Global thoracic aortic aneurysm market: Treatment movement analysis
  • Fig. 17 Global thoracic aortic aneurysm market: Treatment outlook and key takeaways
  • Fig. 18 Open surgical repair (OSR) market estimates and forecast, 2021 - 2033
  • Fig. 19 Thoracic endovascular aneurysm repair (TEVAR) market estimates and forecast, 2021 - 2033
  • Fig. 20 Branched endovascular aneurysm repair (BEVAR) market estimates and forecast, 2021 - 2033
  • Fig. 21 Hybrid procedures market estimates and forecast, 2021 - 2033
  • Fig. 22 Global thoracic aortic aneurysm market: Product movement analysis
  • Fig. 23 Global thoracic aortic aneurysm market: Product outlook and key takeaways
  • Fig. 24 Aortic stent grafts market estimates and forecasts, 2021 - 2033
  • Fig. 25 Aortic surgical grafts market estimates and forecasts,2021 - 2033
  • Fig. 26 Aortic repair accessory devices market estimates and forecasts,2021 - 2033
  • Fig. 27 Global thoracic aortic aneurysm market: End use movement analysis
  • Fig. 28 Global thoracic aortic aneurysm market: End use outlook and key takeaways
  • Fig. 29 Hospitals market estimates and forecasts, 2021 - 2033
  • Fig. 30 Ambulatory surgery centers (ASC) market estimates and forecasts, 2021 - 2033
  • Fig. 31 Clinics market estimates and forecasts, 2021 - 2033
  • Fig. 32 Global thoracic aortic aneurysm market: Regional movement analysis
  • Fig. 33 Global thoracic aortic aneurysm market: Regional outlook and key takeaways
  • Fig. 34 North America thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 35 Key country dynamics
  • Fig. 36 U.S. thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Canada thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Mexico thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 41 Europe thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 42 Key country dynamics
  • Fig. 43 UK thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 44 Key country dynamics
  • Fig. 45 Germany thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Spain thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 48 Key country dynamics
  • Fig. 49 France thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Italy thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Norway thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Denmark thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Sweden thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 58 Asia Pacific thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Japan thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 61 Key country dynamics
  • Fig. 62 China thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 63 Key country dynamics
  • Fig. 64 India thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Australia thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 67 Key country dynamics
  • Fig. 68 South Korea thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Thailand thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 71 Latin America thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Brazil thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Argentina thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 76 MEA thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 77 Key country dynamics
  • Fig. 78 South Africa thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Saudi Arabia thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 81 Key country dynamics
  • Fig. 82 UAE thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Kuwait thoracic aortic aneurysm market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 85 Key company categorization
  • Fig. 86 Heat map analysis 2024